The 10-day moving average for IMRA crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
IMRA moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.
a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies
Category Unknown